Entecavir is a guanosine nucleoside analog that is generally used in the treatment of chronic hepatitis B virus (HBV) infection. The impurity profile of Entecavir includes structurally related analogs, residual solvents, and degradation products. These pharmaceutical impurities impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways of Entecavir API may involve oxidative breakdown of the purine ring, and rearrangement of substituents within the heteroaromatic scaffold. These impurities may affect the potency, stability, and safety of the drug. All impurities are structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.
We provide the pharmacopeial and non-pharmacopeial Entecavir impurity compounds are available in compliance with European Pharmacopoeia (EP) specifications. These standards can support analytical method development, impurity profiling, and long-term stability studies. Thus, EP traceable products are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.
Structurally related compounds and synthetic analogs of Entecavir are included for impurity identification, toxicological qualification, and regulatory submission. These related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.
We also supply the Entecavir impurity reference standards that are provided with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. Thus, EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
